Retrospective Study
Copyright ©The Author(s) 2017.
World J Gastrointest Surg. Mar 27, 2017; 9(3): 73-81
Published online Mar 27, 2017. doi: 10.4240/wjgs.v9.i3.73
Table 2 Demographic and clinical characteristics of overall study population and patients with or without delayed gastric emptying
Overall (n = 276)No DGE group (n = 227)DGE Group (n = 49)P values
Age63.2 ± 11.9262.9 ± 11.9564.6 ± 11.770.348
Gender0.339
Male135 (48.9%)108 (47.6%)27 (55.1%)
Female141 (51.1%)119 (52.4%)22 (44.9%)
Co-morbid conditions
HTN147 (53.3%)119 (52.4%)28 (57.1%)0.568
COPD13 (4.7%)11 (4.8%)2 (4.1%)1
DM67 (24.3%)58 (25.6%)9 (18.4%)0.288
CRI8 (2.9%)6 (2.6%)2 (4.1%)0.635
History of pancreatitis42 (15.2%)36 (15.9%)6 (12.2%)0.557
History of ETOH use122 (44.2%)102 (44.9%)20 (40.8%)0.702
History of tobacco use57 (20.7%)49 (21.6%)8 (16.3%)0.390
BMI (mean ± SD)26.7 ± 7.127.1 ± 7.2825.6 ± 6.910.226
Presenting symptoms
Weight loss140 (50.7%)115 (50.7%)25 (51.0%)0.921
Anorexia29 (10.5%)24 (10.6%)5 (10.2%)0.873
Early satiety17 (6.2%)16 (7.0%)1 (2.0%)0.323
Nausea83 (30.1%)74 (32.6%)9 (18.4%)0.058
Vomiting43 (15.6%)40 (17.6%)3 (6.1%)0.048
Jaundice122 (44.2%)103 (45.4%)19 (38.8%)0.419
Preop albumin4.0 ± 0.604.0 ± 0.593.8 ± 0.620.038
Preop total bilirubin2.5 ± 4.292.7 ± 4.491.8 ± 3.110.139
Preop hemoglobin12.8 ± 1.8512.8 ± 1.8712.7 ± 1.760.734
Preop Cr > 1.240 (14.5%)31 (13.7%)9 (18.4%)0.378